Radium-223: the newest option in metastatic castration-resistant prostate cancer

Clin Adv Hematol Oncol. 2013 Dec;11(12):801-3.
No abstract available

Publication types

  • Interview

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Castration
  • Humans
  • Male
  • Neoplasm Metastasis
  • Portraits as Topic
  • Prostatic Neoplasms / drug therapy*
  • Prostatic Neoplasms / pathology
  • Radioisotopes / therapeutic use
  • Radiopharmaceuticals / therapeutic use*
  • Radium / therapeutic use*

Substances

  • Antineoplastic Agents
  • Radioisotopes
  • Radiopharmaceuticals
  • radium Ra 223 dichloride
  • Radium